First tilapia fingerlings from the new GenoMar Genetics facility delivered to the market in Vietnam
From its new production base in the Tay Ninh province, GenoMar Genetics Vietnam (GGV) achieved an important milestone last week by successfully shipping genetically improved fingerlings for the first time to a customer in the Hai Duong province in northern Vietnam.
Quick progress made by the Vietnamese team
GenoMar is very impressed by the agility and execution capabilities of the Vietnamese team despite the challenges brought by COVID-19, says Alejandro Tola Alvarez, CEO at GenoMar Genetics Group. They imported Specific Pathogen Free (SPF) tilapia larvae parent stock from our nucleus facility in the Philippines in March 2021 and delivered the first fingerlings from the new site in August 2021. Having products in the market in such a short period of time reflects the tremendous effort the team has made to carry out our plans, Alvarez adds.
Biosecurity, all year-round production, and superior genetics to support the development of a sustainable tilapia industry. The facility is strategically located and designed to maintain a steady supply of SPF eggs, larvae, and fingerlings throughout the year. This is two of our most important values for successful farming, says Nguyen Van Trung, General Manager at GGV.
Most of the fingerlings in the market now are either produced in northern Vietnam or imported from China. The supply from these areas is seasonal since black tilapia production are exposed to climatic conditions that inhibits tilapia reproduction and production of eggs. The industry therefore struggles to get starting material in parts of the year. Furthermore, with most of the tilapia fingerlings being imported by informal ways from China, securing disease free starting material is a real challenge and an area where GGV intends to make strong contributions.
As a primary breeder at the top of the value chain, GenoMar takes health management very seriously, Trung continues. The Vietnamese parent stocks are SPF, the facility is designed with biosecurity principles, and the group is implementing comprehensive health management plans and metrics.
The fingerlings will turn into a fast-growing and robust fish
The product in this first-time delivery that took place on August 31st, 2021, is produced from the 30th generation of GenoMar’s broodstock in Asia. The fish has been bred for fast growth and general robustness from the early beginning and is also specifically selected for resistance to Streptococcosis and fillet yield, says Anders Skaarud, who works as a Senior Researcher at the company labs in Norway.
GenoMar Group is noticing strong interest in the market for products to a point where all our expected production for the next months is already sold out. The focus now will be to follow up the performance of the fish under Vietnamese farming conditions and opening a second hatchery farm in the Red River area in northern Vietnam, Trung finalizes.
About GenoMar Genetics GroupGenoMar Genetics Group is an international aquaculture breeding and distribution company focusing on the global tilapia markets. From our breeding centres in Norway, Latin America, and Asia, we manage innovation and technology programs for some of the most recognized independent brands in the industry such as GenoMar, Aquabel and AquaAmerica. Our production infrastructure enables to quickly disseminate genetic progress and supply year-round, high-quality stocks to our clients contributing to a sustainable and profitable tilapia industry. |
For more information, please contact: Alejandro Tola Alvarez, CEO, GenoMar Genetics Group +47 483 28 271 alex@genomar.com
Nguyen Van Trung, General Manager, GenoMar Genetics Vietnam +84 932 651 188 vincent.nguyen@genomar.com |
GenoMar Vietnam